Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder-Reference-Cited by-同舟云学术

Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder

Published:2016-07 Issue:4 Volume:10 Page:236-243
ISSN:1932-0620
Container-title:Journal of Addiction Medicine
language:en
Short-container-title:

Author:

Mooney Larissa J.,Hillhouse Maureen P.,Thomas Christie,Ang Alfonso,Sharma Gaurav,Terry Garth,Chang Linda,Walker Robrina,Trivedi Madhukar,Croteau David,Sparenborg Steven,Ling Walter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference36 articles.

1. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial;Anderson;Drug Alcohol Depend,2015

2. Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward;Anggadiredga;Brain Res,2004

3. Bupropion: a review of its mechanism of antidepressant activity;Ascher;J Clin Psychiatry,1995

4. The empirical foundations of telemedicine interventions for chronic disease management;Bashshur;Telemed e-Health,2014

5. Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss;Billes;Pharmacol Res,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial;Addiction;2024-06-10

2. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder;Journal of Addiction Medicine;2024-05

3. Provocative repetitive transcranial magnetic stimulation to reduce craving in methamphetamine use disorder;Journal of Clinical Psychiatry;2024

4. Integrative Pharmacology in the Treatment of Substance Use Disorders;Journal of Dual Diagnosis;2023-12-20

5. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial;Journal of Substance Use and Addiction Treatment;2023-08